10
Participants
Start Date
August 8, 2022
Primary Completion Date
October 3, 2025
Study Completion Date
October 3, 2025
PF-06939926
All participants will receive a single dose of PF-06939926 on Day 1.
The Children's Hospital at Westmead, Westmead
The Royal Children's Hospital Melbourne, Parkville
Perth Children's Hospital, Nedlands
The Children's Hospital of Philadelphia, Philadelphia
The Children's Hospital of Philadelphia, Philadelphia
UF Health Shands Hospital, Gainesville
University of Florida, Gainesville
CTSI Clinical Research Center, Salt Lake City
University of Utah Imaging and Neurosciences Center, Salt Lake City
University of Utah Hospital & Clinics Investigational Drug Services, Salt Lake City
Primary Children's Hospital, Salt Lake City
University of Utah Clinical Neurosciences Center, Salt Lake City
University of Utah Hospital, Salt Lake City
Lead Sponsor
Pfizer
INDUSTRY